Sentences with phrase «disease genomics research»
While the past few years have seen substantial federal and private research funding for infectious disease genomics research, there has been little discussion of the possible ELSIs - for individuals, groups or larger society - of using genomic information in the management of infectious disease.
https://genomemedicine.biomedcentral.com/ Not exact matches
His research has spanned hematopoiesis, gene therapy, stem cell biology, genomics and cancer, consistently focusing on bringing the very latest research advances to patients with heretofore incurable diseases.
Wth technology addressing skin microbial therapeutics, fertility science, chronic disease alleviation, post traumatic stress disorder treatments, and services for the biopharmaceutical and clinical research industries; the startups selected by Illumina will have access to the company's genomics and sequencing expertise, business coaching, lab and office space and an infusion of capital.
To help reduce that disease risk, a team led by pioneering genomics research J. Craig Venter...
«The diagnostics lab Baylor Genetics is one of the pioneers in this new era of clinical genomics - supported medical practice and disease gene discovery research,» Lupski said.
The inflammation cluster research groups led by Saleh Ibrahim of the University of Lübeck, and John Baines of the MPI and CAU, correlated the genomic variations of hundreds of mice that partially develop skin inflammatory diseases with skin microbiota.
A decade ago, this week, scientists at the University of Texas Health Science Center at Houston and the Institute for Genomic Research announced they had decoded the genetic information inside Treponema pallidum, the bacterium that causes the sexually transmitted disease (STD) syphilis.
Her research group focuses on developing dynamic models for effective infectious disease management for HIV, hepatitis, and genomics.
Maine also approved bond measures to create an animal and plant disease and insect control lab, build a genomics and disease research center, and modernize and expand a biological lab specializing in tissue repair and regeneration.
The genomics era has had a profound impact on life science research, leading to significant developments such as the use of expression quantitative trait loci (eQTLs), which link polymorphisms in single genes to quantifiable changes in gene expression associated with specific diseases.
The regulatory function of novel targets will be validated in collaboration with Judy H. Cho, MD, Ward - Coleman Professor of Medicine and Genetics and Genomic Sciences, and Assistant Chief of Research in the Gastrointestinal Division, and Jean Federic Colombel, MD, Professor of Medicine and Director of the Leona M. and Harry B. Helmsley Charitable Trust Inflammatory Bowel Disease Center, at they Icahn School of Medicine at Mount Sinai.
The team, led by ICREA research professor Gian Gaetano Tartaglia at the CRG, is using genomics to advance our understanding of Parkinson's disease.
Investigators with The Cancer Genome Atlas (TCGA) Research Network have identified novel genomic and molecular characteristics of cervical cancer that will aid in the subclassification of the disease and may help target therapies that are most appropriate for each patient.
Maine: Voters approved Question 4, 63.1 % to 36.9 %, providing $ 10 million in bonds, to be matched by $ 11 million in private funds, to build a genomics and disease research center at the Maine Technology Institute in Brunswick.
To help detect genetic mutations and better understand this disease, a group of researchers at USU and the nationwide Cancer Genome Atlas Research Network examined 173 tumors, performing six genomic tests, such as DNA and RNA sequencing.
This work was supported in part by the Center for Research in FOP and Related Disorders, the International FOP Association, the Ian Cali Endowment, the Weldon Family Endowment, the Penn Center for Musculoskeletal Disorders, the Isaac and Rose Nassau Professorship of Orthopaedic Molecular Medicine, and the Deutsche Forschungsgemeinschaft (SFB760 to P. Seemann and S. Mundlos); by Health and Labour Science Research Grants for Research on Measures for Intractable Disease Research and the Academic Frontier Project of Saitma Medical University Research Center for Genomic Medicine, both from the Ministry of Education, Culture, Sports, Sciences, and Technology of Japan (to T. Katagiri); and by grants from the Rita Allen Foundation and the NIH (R01 - GM056326 to M.C. Mullins; R01 - AR40196 to F.S. Kaplan and E.M. Shore).
A collaboration of premier academic, medical and industry leaders across the globe, the New York Genome Center has as its goal to translate genomic research into the development of new treatments, therapies and therapeutics against human disease.
The code does not place unrealistic demands on scientists, says Himla Soodyall, director of the Human Genomic Diversity and Disease Research Unit at South Africa's University of the Witwatersrand in Johannesburg.
The NHGRI Division of Intramural Research develops and implements technology to understand, diagnose and treat genomic and genetic diseases.
Fundraising Priorities Genomics Wolfe Chair in Gene Function Genomic Analysis of Vascular Neuroscience Barnett Chair for Medical Research Director Molecular Brain Research — Chair in Alzheimer's Research Molecular Brain Research — Concussion Research Molecular Brain Research — Disease Research Molecular Brain Research — Spinal Cord Research
Join our Connecticut nonprofit biomedical research institute, which is focused on accelerating the discovery of precise genomic solutions for diseases like cancer, autism, diabetes and Alzheimer's.
The INFRAFRONTIER mission: ◊ to shape the European Research Area in the field of mouse functional genomics and thereby make an important contribution to the study of human disease.
These and other ethical, legal and social challenges need to be considered when designing and conducting genomic research on host factors and host - vector - pathogen interactions in Ebola virus disease.
Research interests: primate comparative genomics, adaptive evolution, human brain evolution, infectious diseases in primate hosts, HIV / SIV and AIDS, evolutionary medicine, colobines
He recently moved back to academia as an associate professor in the departments of Neuroscience and Human Genetics & Genomic Sciences at the Icahn School of Medicine at Mount Sinai in New York, where he continues his basic research and translational efforts in AD using a state - of - the - art experimental and computational toolkit, in collaboration with Drs. Alison Goate and Anne Schaefer within the Ronald M. Loeb Center for Alzheimer's Disease.
As such, genomic research is improving our understanding of infectious disease pathogenesis and immune response and may help guide future vaccine development and treatment strategies [11][18].
More than two decades of ELSI research on the application of genomics to complex diseases has produced many insights that are also relevant to infectious diseases [19].
June 6, 2016 Genomic Data Commons at University of Chicago heralds new era of data sharing for cancer research The Genomic Data Commons (GDC), a next - generation platform that enables unprecedented data access, analysis and sharing for cancer research, publicly launched at the University of Chicago on June 6, opening the door to discoveries for this complex set of diseases.
In this 3 - year phase, Broad scientists worked closely with Mexican colleagues from 17 academic and research institutions led by the Mexican National Institute of Genomic Medicine, to systematically identify genes underlying cancer, diabetes and kidney disease, and to build capacity in Mexico in genomic meGenomic Medicine, to systematically identify genes underlying cancer, diabetes and kidney disease, and to build capacity in Mexico in genomic megenomic medicine.
The Genomic Data Commons (GDC), a next - generation platform that enables unprecedented data access, analysis and sharing for cancer research, publicly launched at the University of Chicago on June 6, opening the door to discoveries for this complex set of diseases.
Dr. Torkamani's research covers a broad range of areas centered on the use of genomic technologies to identify the genetic etiology and underlying mechanisms of human disease in order to define precision therapies for diseased individuals.
Importantly, he subsequently published the sequence on the CSHL website (www.cshl.edu), a boon to public understanding of genomics and its promise in disease research.
Based in Reykjavík, Iceland, deCODE genetics is a population - based genomics company, conducting research in the genetics of 35 common diseases.
Her research incorporates genomics, computational biology, and molecular biology techniques to investigate the infectious agents that cause diseases endemic to tropical climates and those that have more global reach.
Other Institutions also belong to the Campus: the University of Milan; Cogentech, an IFOM - IEO consortium committed to developing leading genomic technologies (nanotechnologies, proteomics, bioinformatics, disease models), the European School of Molecular Medicine (SEMM), that organizes training in emerging sectors of Biomedicine, offering the first European PhDs in Molecular Medicine, Medical Nanotechnologies, Foundations of the Life Sciences and their Ethical Consequences; Genextra, a biotech company whose mission is to develop new therapies against cancer and aging - related disease; Biopolo, a not for profit company involved in the technological transfer of basic research to the productive system.
The families were ascertained from multiple sites, including contributors to the Alzheimer Disease Genetics Consortium (ADGC), and the neurology working group of the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium (CHARGE).
H3Africa Initiative aims to facilitate a contemporary research approach to the study of genomics and environmental determinants of common diseases with the goal of improving the health of African populations.
Included among the numerous recipients of Mr. Sanford's gifts, that total more than one billion dollars, are: the Edith Sanford Foundation for Breast Cancer that was created in 2012 by a gift of $ 100 million in honor of Mr. Sanford's mother who died of breast cancer when he was four years old; the Sioux Valley Hospitals and Health System, which renamed itself Sanford Health in 2007, in recognition of a $ 400 million gift; a $ 125 million gift in 2014 to establish Sanford Imagenetics, a program that will integrate genomic medicine into primary care for adults; the University of California San Diego which received a $ 100 million gift for the creation of the Sanford Stem Cell Clinical Center in 2013 to accelerate the translation of stem cell research discoveries by advancing clinical trials and patient therapies; the Burnham Institute for Medical Research that received a $ 50 million gift in 2010, and recognized its appreciation for both this and a 2008 gift of $ 20 million to the Sanford Center for Childhood Disease research at Burnham by then changing its name to Sanford Burnham Medical Research Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative Mresearch discoveries by advancing clinical trials and patient therapies; the Burnham Institute for Medical Research that received a $ 50 million gift in 2010, and recognized its appreciation for both this and a 2008 gift of $ 20 million to the Sanford Center for Childhood Disease research at Burnham by then changing its name to Sanford Burnham Medical Research Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative MResearch that received a $ 50 million gift in 2010, and recognized its appreciation for both this and a 2008 gift of $ 20 million to the Sanford Center for Childhood Disease research at Burnham by then changing its name to Sanford Burnham Medical Research Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative Mresearch at Burnham by then changing its name to Sanford Burnham Medical Research Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative MResearch Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative MResearch Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative Medicine.
It is essential that cutting - edge genomic research translates into clinical care helping to understand the biology of rare diseases.
With key strengths in advanced medical imaging, cell biology, genomics, immunology and stem cell biology, our scientists and their skilled staff conduct research on some of the most debilitating diseases of our time: heart disease and stroke, Alzheimer's, cancer, organ failure, diabetes and many others.
The JCVI teams are focused on a variety of genomic research areas including continued work in synthetic biology; sampling and analysis of the world's oceans, fresh water and soils to better understand the microbes living in these environments; and new analysis on the human genome in the hopes of discovering new insights into disease prevention and treatment.
Ageing research and more generally the study of the functional basis of human diseases profit enormously from the large - scale approaches and resources in mouse functional genomics: systematic targeted mutation of the mouse genome, systemic phenotyping in mouse clinics, and the archiving and distribution of the mouse resources in public repositories.
The project is part of the USDA's focus on supporting research in plant breeding, genetics, and genomics to improve crops, identify and address threats from pests and diseases, and, create new technologies and tools for plant breeders.
Much additional research and development is needed to translate advances in DNA sequencing and genomics into reconnaissance tools for clinicians and public health officials on the frontline of the fight against infectious diseases.
Diversity in Genomics Research Cohorts The lack of diversity within participant cohorts in genetics and genomics research limits our ability to study variation across the human genome and the genetic factors that influence health and disease, as well as our ability to ensure that every segment of the population is able to benefit from advances stemming from the rResearch Cohorts The lack of diversity within participant cohorts in genetics and genomics research limits our ability to study variation across the human genome and the genetic factors that influence health and disease, as well as our ability to ensure that every segment of the population is able to benefit from advances stemming from the rresearch limits our ability to study variation across the human genome and the genetic factors that influence health and disease, as well as our ability to ensure that every segment of the population is able to benefit from advances stemming from the researchresearch.
NIAID's biodefense research is integrated into its larger emerging and re ‐ emerging infectious diseases portfolio that uses sophisticated genomic and proteomic platforms focused on developing broad ‐ spectrum therapies effective against entire classes of pathogens.
This data sharing deepens our understanding of variability in the human genome and the genetic underpinnings of disease, leading to advances in genomics research and genomic medicine.
Topics covered include embryonic stem cells, pluripotency, germline stem cells, tissue - specific stem cells, stem cell differentiation, epigenetics, stem cell genomics and systems biology, genome reprogramming, cancer stem cells, stem cell niches, stem - cell - based disease models, nuclear transfer technology, bioengineering, drug discovery, in vivo imaging of stem cells, therapeutic applications, regenerative medicine, clinical and translational insights, stem cell research policies, ethical issues, and technical or resource - based innovations.
Center will utilize next generation genomic sequencing and analysis technologies to better understand infectious disease pathogens, and create resource for the research community
Rick Kittles has been researching ancestry - informative genetic markers and how they can be utilizes in genomic studies on disease risk and outcomes for more than 20 years.